Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

1.93
+0.16009.04%
Volume:1.63M
Turnover:2.98M
Market Cap:168.69M
PE:-6.17
High:1.94
Open:1.79
Low:1.74
Close:1.77
52wk High:1.94
52wk Low:0.3418
Shares:87.41M
Float Shares:46.13M
Volume Ratio:0.49
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3127
EPS(LYR):-1.6093
ROE:-14.24%
ROA:-4.47%
PB:0.96
PE(LYR):-1.20

Loading ...

Top Midday Gainers

MT Newswires Live
·
Yesterday

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

TIPRANKS
·
Yesterday

Century Therapeutics Shares Hit 52-Week High After Private Placement Deal

Dow Jones
·
Jan 08

BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813

Reuters
·
Jan 08

Century Therapeutics Inc - Financing Led by Tcgx With Multiple Investors Participating

THOMSON REUTERS
·
Jan 08

Press Release: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes

Dow Jones
·
Jan 08

Chief Scientific Officer Chad Cowan Reports Acquisition of Century Therapeutics Inc Common Shares

Reuters
·
Dec 30, 2025

Century Therapeutics Director Carlo Rizzuto Resigns

Reuters
·
Dec 30, 2025

3 Promising Penny Stocks With Market Caps Over $30M

Simply Wall St.
·
Dec 19, 2025

Century Therapeutics CEO Brent Pfeiffenberger Reports Acquisition of Common Shares

Reuters
·
Dec 17, 2025

Century Therapeutics Inc Files Initial Statement of Beneficial Ownership for Director Han Myung Lee

Reuters
·
Dec 12, 2025

Century Therapeutics Appoints Han Lee and Martin Murphy to Board

Reuters
·
Dec 09, 2025

Press Release: Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

Dow Jones
·
Dec 09, 2025

We're Keeping An Eye On Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate

Simply Wall St.
·
Nov 30, 2025

Century Therapeutics CEO Brent Pfeiffenberger Reports Acquisition of Common Shares

Reuters
·
Nov 21, 2025

Century Therapeutics CEO Makes Significant Stock Sale!

TIPRANKS
·
Nov 20, 2025

Century Therapeutics Shares Fall After Leerink Partners Downgrade

MT Newswires Live
·
Nov 18, 2025

Century Therapeutics (IPSC) Gets a Buy from Clear Street

TIPRANKS
·
Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform

MT Newswires Live
·
Nov 17, 2025

Century Therapeutics Q3 net loss widens, despite lower costs

Reuters
·
Nov 13, 2025